Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-02-01
2005-02-01
Weber, Jon P. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S324000, C530S300000, C435S440000, C435S069100, C424S278100, C536S023100
Reexamination Certificate
active
06849601
ABSTRACT:
The present invention relates to novel peptides and derivatives thereof useful as selective α1-adrenoceptor antagonists which ability of inhibiting the agonist action of agonist noradrenaline on the α1-adrenoceptor is greater than their ability of inhibiting the action of agonist noradrenaline on the other α-adrenoceptors. The invention also relates to pharmaceutical compositions comprising these peptides.
REFERENCES:
patent: WO 9511256 (1995-04-01), None
patent: WO 9824462 (1998-06-01), None
patent: WO 9921878 (1999-05-01), None
patent: WO 9933482 (1999-07-01), None
Alonso, D. et al. (2003) Drugs from the sea: conotoxins as drug leads for neuropathic pain and other neurological conditions. Mini Rev Med Chem. vol. 3, pp. 785-787. Review.
Alewood Paul Francis
Lewis Richard James
Sharpe Iain Andrew
Liu Samuel W.
Scully Scott Murphy & Presser
The University of Queensland
Weber Jon P.
LandOfFree
Peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3496305